AMI: The Scale Of The Problem
Main Category: Cardiovascular / CardiologyArticle Date: 02 Sep 2009 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Acute myocardial infarction (AMI) remains one of the leading causes of death in the Western world, with prevalence predicted to increase dramatically in developing countries, especially India and China. Around 40-50% of AMIs are the result of a persistent, complete thrombotic occlusion of a coronary artery. In such cases fast reopening of the infarct vessel is the primary goal of treatment.
This "reperfusion" therapy has been shown to save lives, especially when applied with 2-3 hours after the onset of infarction. Recanalisation of the infarct vessel can be obtained by administering thrombolytic agents (to dissolve the occlusive thrombus) or by performing a mechanical recanalisation followed by angioplasty of the culprit lesion (primary percutaneous intervention, PCI).
Primary PCI can open significantly more vessels than thrombolytic therapy, and therefore save more lives, but it can only be performed in facilities with a cath lab and an experienced team on stand-by.
Getting patients with an AMI to a PCI centre in the shortest possible time is a major challenge which requires a close collaboration between cardiologists of different hospitals and the emergency medical system. The ESC and health authorities in different countries are currently taking many initiatives to set-up these networks.
Source:
Jacquelline Partarrieu
European Society of Cardiology
Visit our cardiovascular / cardiology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/162580.php>
APA
http://www.medicalnewstoday.com/releases/162580.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




